193 related articles for article (PubMed ID: 38163876)
1. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
[TBL] [Abstract][Full Text] [Related]
2. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
Shan BQ; Wang XM; Zheng L; Han Y; Gao J; Lv MD; Zhang Y; Liu YX; Zhang H; Chen HS; Ao L; Zhang YL; Lu X; Wu ZJ; Xu Y; Che X; Heger M; Cheng SQ; Pan WW; Zhang X
Cancer Sci; 2022 May; 113(5):1587-1600. PubMed ID: 35178836
[TBL] [Abstract][Full Text] [Related]
3. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G
Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431
[TBL] [Abstract][Full Text] [Related]
4. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
5. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
Xu J
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
[TBL] [Abstract][Full Text] [Related]
6. The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic resumption by targeting PTEN degradation.
Zhang J; Zhang YL; Zhao LW; Pi SB; Zhang SY; Tong C; Fan HY
Cell Mol Life Sci; 2020 Jun; 77(11):2181-2197. PubMed ID: 31492966
[TBL] [Abstract][Full Text] [Related]
7. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway.
Shen D; Zeng Y; Zhang W; Li Y; Zhu J; Liu Z; Yan Z; Huang JA
Eur J Pharmacol; 2022 May; 923():174925. PubMed ID: 35364069
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.
Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X
PeerJ; 2022; 10():e13402. PubMed ID: 35646490
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.
Zheng Y; Zhou Z; Wei R; Xiao C; Zhang H; Fan T; Zheng B; Li C; He J
J Transl Med; 2022 Jul; 20(1):343. PubMed ID: 35907982
[TBL] [Abstract][Full Text] [Related]
10. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma.
Wei S; Lu K; Xing J; Yu W
FASEB J; 2023 Apr; 37(4):e22849. PubMed ID: 36884358
[TBL] [Abstract][Full Text] [Related]
11. LINC00491 Facilitates Tumor Progression of Lung Adenocarcinoma via Wnt/β-Catenin-Signaling Pathway by Regulating MTSS1 Ubiquitination.
Wan H; Lin T; Shan M; Lu J; Guo Z
Cells; 2022 Nov; 11(23):. PubMed ID: 36496997
[No Abstract] [Full Text] [Related]
12. LncRNA CASC2 inhibits lung adenocarcinoma progression through forming feedback loop with miR-21/p53 axis.
Wu ZH; Zhou J; Hu GH; Liu J; Li WC; Lai XH; Liu M
Kaohsiung J Med Sci; 2021 Aug; 37(8):675-685. PubMed ID: 34337857
[TBL] [Abstract][Full Text] [Related]
13. TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.
Yu S; Li W; Liu X; Zhang H; Liu X; Zhang LW
Biochem Biophys Res Commun; 2022 Nov; 628():1-10. PubMed ID: 36058131
[TBL] [Abstract][Full Text] [Related]
14. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
Yu B; Zhou Y; He J
Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
[TBL] [Abstract][Full Text] [Related]
15. RNF182 induces p65 ubiquitination to affect PDL1 transcription and suppress immune evasion in lung adenocarcinoma.
Zeng X; Tang X; Chen X; Wen H
Immun Inflamm Dis; 2023 May; 11(5):e864. PubMed ID: 37249301
[TBL] [Abstract][Full Text] [Related]
16. CRL4
Ren P; Tong X; Li J; Jiang H; Liu S; Li X; Lai M; Yang W; Rong Y; Zhang Y; Jin J; Ma Y; Pan W; Fan HY; Zhang S; Zhang YL
Cell Mol Life Sci; 2024 Apr; 81(1):165. PubMed ID: 38578457
[TBL] [Abstract][Full Text] [Related]
17. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
19. MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4B
Chen Z; Zhang W; Jiang K; Chen B; Wang K; Lao L; Hou C; Wang F; Zhang C; Shen H
Mol Ther Nucleic Acids; 2018 Mar; 10():254-268. PubMed ID: 29499938
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma.
Lu T; Xu R; Wang C; Zhou X; Parra-Medina R; Díaz-Peña R; Peng B; Zhang L
J Thorac Dis; 2023 Jul; 15(7):3885-3907. PubMed ID: 37559628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
